Please enable JS

Investors

Press Releases

 
Press Releases
  Date Title View
May 3, 2016
CAMBRIDGE, Mass., May 03, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the first quarter ended March 31, 2016. For the first quarter of 2016, the Company reported total revenues of $19.9 million, including $14.8 million in product revenues from Sandoz's sale of Glatopa® (g...
Apr 26, 2016
CAMBRIDGE, Mass., April 26, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), announced today that is has changed the time for its first quarter 2016 earnings conference call and webcast. Momenta will now host its conference call and webcast at 9:00 a.m. EDT on Tuesday, May 3, 2016.    To access the call, please dial (877) ...
Apr 25, 2016
CAMBRIDGE, Mass., April 25, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.Deutsche Bank 41st Annua...
Apr 19, 2016
CAMBRIDGE, Mass., April 19, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the first quarter ended March 31, 2016 before the U.S. financial markets open on Tuesday, May 3, 2016. Manageme...
Mar 9, 2016
CAMBRIDGE, Mass., March 09, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of Jose-Carlos (JC) Gutiérrez-Ramos, Ph.D. to its Board of Directors effective March 9, 2016.  Dr. Gutiérrez-Ramo...
Feb 24, 2016
CAMBRIDGE, Mass., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences. Cowen & Company 36th Annual Health Care ConferenceMonday, M...
Feb 18, 2016
CAMBRIDGE, Mass., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the fourth quarter and year ended December 31, 2015. For the fourth quarter of 2015, the Company reported total revenues of $22.4 million, including $15.6 million in product revenues from Sandoz's sale of G...
Feb 10, 2016
CAMBRIDGE, Mass., Feb. 10, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act...
Feb 5, 2016
CAMBRIDGE, Mass., Feb. 05, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the fourth quarter and year ended December 31, 2015 before the U.S. financial markets open on Thursday, February 18, ...
Feb 1, 2016
CAMBRIDGE, Mass., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences. Leerink Partners 5th Annual Global Healthcare ConferenceWed...
1
...
NextLast
= add release to Briefcase